Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Sarsblog.com Presents The Risks of Reopening the World Without Having A Cure For Covid-19


News Image

Covid-19 once has caused significant upheaval around the globe. Hospitals are still overwhelmed with patients. Without a definitive timeline around the development of vaccines or medications, there is no clear schedule for reopening the economy. Sarsblog.com recently launched a new article that discusses about the current situation and the recommended preemptive measures.

The CDC drafted a 3-phase reopening roadmap. Each phase includes guidelines for organizations including, schools, camps, childcare centers, religious facilities and mass transit systems that emphasize strict control and social distancing measures. Although the guidelines can only serve as advice and it is up to the individual states to enforce them, it is likely that the states will adapt similar guidelines.

The take away from the guidelines is that social distancing measures will still be incorporated in our lives to ensure the health-safety of the population. However, people will need to eventually go back to work in order to put food on the table. But it will have to be done with a lot of caution and discipline.

Although there is some progress in flattening the infection curve, there are still worries about going backwards and, possibly, facing another wave of infection — especially if the timing coincides with the seasonal flu. These will severely affect each country’s options for reopening its economy. The only viable solution for getting rid of this virus is the developing of a vaccine

In order to mitigate the risks of getting infected, the authorities recommend:

1) Stay healthy and keep the immune system strong. Eating right, exercising daily and getting sufficient amount of sleep will help people have a strong immune system

2) Limit human contact as much as possible. Work remotely as much as possible, go out only when it is necessary, and maintaining 2 meters (about 6 feet) distance when out in public. Almost all countries have adopted social distancing rules.

3) Wash and sanitize hands properly, clean and disinfect surfaces, and ventilate homes and offices frequently.

4) Wear personal protective equipment (PPE) —such as masks, goggles, and gloves.

According to the CDC, transmission occurs much more commonly through respiratory droplets than through fomites. This means that maintaining the 2-meter (about 6 feet) distance and wearing protective equipment— including masks, goggles, and gloves are going to be a priority when in public.

Finding PPE can be problematic and many countries faced critical shortages, including the USA. Protecting ourselves from scams and fraudsters taking advantage of the situation is another issue. One solution would be to track companies that have experience in dealing with disasters. For example, ANNI Medical which is the sister company of ANNI K.K, a company that works closely with UNICEF Japan. They had successfully delivered emergency supplies for UNICEF in the March 11, 2011 earthquake and the Fukushima disaster that followed. The company has announced that it can manufacture up to 50,000 masks per day.

While the COVID-19 outbreak is still declared a pandemic, opening the economy is an issue and the long-term consequences might outweigh the immediate benefits.

Share article on social media or email:

California Based Company Supports Medical Practices During Coronavirus Pandemic With Free Telemedicine Technology


Canvas Live, Telemedicine Services

Roya.com Offers Free Telemedicine Services to Medical Professionals

Understanding that all businesses and medical practices are financially impacted, it was important that we did our part.

Healthcare digital marketing technology and services leader, Roya.com, announced a new telemedicine solution, CANVAS® LIVE, to further support healthcare professionals during a time with an ever growing demand for Telehealth services. CANVAS® LIVE, is a new addition to the existing Canvas® platform that will allow Medical professionals to virtually communicate with patients in a HIPAA-compliant, secure video-chat platform, eliminating the need for in-person appointments.

Roya.com has made telemedicine easy to use and easy to access for medical professionals and their patients alike. CANVAS® LIVE allows health care professionals to remotely care for patients in a professional, secure platform that is embedded directly on their website. Unlike other Telemedicine services, CANVAS® LIVE does not require downloading or installing third-party apps or software, and is designed to be integrated natively on the Medical Professional’s existing website to create a personal ‘waiting room’ for each pre-approved appointment; generating a secure session that is private and confidential between the Doctor and their patient.

Roya.com felt the social responsibility to develop this product and make it widely available to all medical professionals at this time of uncertainty. “Understanding that all businesses and medical practices are financially impacted, it was important that we did our part,” said Mo Ranji, CEO at Roya.com.

Roya.com is offering CANVAS® LIVE to all Medical Professionals free of charge for the duration of this pandemic. To learn more about CANVAS® LIVE, or to see if you qualify for this free product as a medical professional, visit roya.com/canvas-live or call 858-345-5500 to claim your free telemedicine solution and start communicating with patients today!

Share article on social media or email:

ERI Global Assembles International Coalition to Provide 100-Percent Reimbursable COVID-19 Tests to Hospitals


News Image

With hospitals losing revenue as they struggle under the burden of COVID-19 cases, the U.S.-based medical services firm ERI Global Inc. has assembled an international network of companies that manufacture and distribute COVID-19 tests in a way that is 100 percent reimbursable to hospitals.

Presently, U.S. hospitals are hemorrhaging cash and laying off medical staff, as hospitals are focused on COVID-19 cases and are prevented from conducting other medical services and surgeries that finance hospital operations and staff salaries.

Meanwhile, manufacturers are struggling to match the capacity they have to produce testing kits and other supplies with the right customers – all while millions of Americans await their chance to receive a test.

“I find it unfathomable that the entire world is in dire need of all of these products immediately, the manufacturers cannot keep up with demand, and the hospitals are either furloughing thousands of employees or closing-down all together,” said ERI President Bobbie Celler. “There is a better way and by working together in a more organized manner, we can provide these vital tests more efficiently to where they are needed most.”

One solution is a little-noticed facet in the recent stimulus packages from Washington, D.C. Last week, the White House and the Centers for Medicare & Medicaid Services announced that COVID-19 testing kits will be reimbursed at $100 per test for healthcare facilities and other medical providers. Celler said this essentially makes them free to hospitals that use the proper procedures. (For more information on the CMS action, see this link.)

“CMS has made a critical move to ensure adequate reimbursement for advanced technology that can process a large volume of COVID-19 tests rapidly and accurately,” CMS Administrator Seema Verma said in the announcement last week. “This is an absolute game-changer for nursing homes, where risk of coronavirus infection is high among our most vulnerable.”

ERI’s organization has assembled FDA-approved domestic and global manufacturers, as well as foreign governments and medical consortiums, into the largest group purchasing initiative since the outbreak of the coronavirus. This, coupled with a procurement/reimbursement hybrid, allows U.S. hospitals to obtain a 100-percent reimbursement while simultaneously providing the American public with desperately needed testing products.

“We are all looking for ways to navigate through these unprecedented times,” Celler said. “We know that by banding together we can draw on our many strengths to tackle this crisis.”

For more information on gaining access to FDA-approved COVID-19 testing kits, contact supplychain@EriGlobal.com to be added to the list.

About ERI Global:

Based in New York, NY, ERI Global, Inc. has contracted with over 400 Hospitals and generated more than $500M in gross revenue since 2011 and has worked with many of the Top 30 United States Healthcare Systems in identifying lost insurance revenue and transforming healthcare systems’ revenue cycles. For more information, visit eriglobal.com.

Media Contact:

Richard Mullins

(813) 228-0652 x1127

rmullins@tuckerhall.com

Share article on social media or email:

Insigniam Partner Jon Kleinman Appointed as Advisor to The APANDEMIC Initiative To Combat Patient Deaths From COVID-19


“I am honored to be a part of this incredibly important initiative,” said Mr. Kleinman. “Insigniam exists to serve, and I look forward to being of service to this incredible group of dedicated, passionate professionals who have come together in a shared commitment to the health of all human beings.”

Jon Kleinman, a partner at the international management consulting firm, Insigniam, was recently appointed to serve on the advisory board of the APANDEMIC Initiative. He will serve among the group of physicians, medical researchers, therapy developers, data scientists, engineers, and organizational leaders who have joined forces to help end the COVID-19 crisis.

“I am honored to be a part of this incredibly important initiative,” said Mr. Kleinman. “Insigniam exists to serve, and I look forward to being of service to this incredible group of dedicated, passionate professionals who have come together in a shared commitment to the health of all human beings.”

The APANDEMIC Initiative’s purpose is to deliver access to promising investigational therapies to all patients whose lives are threatened by COVID-19. The organization formed based on a vision to radically transform and accelerate the development, approval, and access to new therapies. As an advisor, Jon brings over two decades of experience in organizational transformation, innovation and breakthrough thinking to the group.

The APANDEMIC Initiative states of their intention, “In our approach, patients are offered immediate and broad access to promising investigational therapies. Importantly, their clinical outcomes are tracked and evaluated in real-time, using 21st-century science, methods, and digital technology. This can be achieved through a Real-World Evidence Master Protocol on an Integrated Research Platform (RWE-IRP).”

About Insigniam

For over 30 years, Insigniam has consulted with large, complex organizations in generating breakthroughs in strategic results: top-line growth, strategy implementation, improving profitability, strategic innovation, and cultural transformation. Insigniam pioneered the fields of organizational transformation and strategy innovation by marrying breakthrough performance and innovation, creating services and solutions that are unparalleled in their potency to quickly create dramatic growth and market leadership. Clients have documented, in aggregate, more than 50x ROI in results considered critical and essential to the success of their enterprises. Offices are located in Southern California, Paris, and Philadelphia.

Share article on social media or email:

Flagship Biosciences and Corritori Consulting Announce Strategic Alliance


Flagship Biosciences, Inc. Logo

Together, Flagship and Corritori integrate seamlessly with a client’s development team through the entire development process to better ensure FDA and therapeutic success.

Flagship Biosciences, providers of expert tissue data insights, today announced an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory services advisor. The companies now deliver regulatory strategy and support to clients in the pharmaceutical and companion diagnostics industries. Flagship and Corritori are taking a collaborative approach to empower more confident and informed regulatory decisions through every phase of the drug development life cycle, for faster development and improved patient care and response.

Navigating the complex world of drug and companion diagnostic development can be a challenge. Flagship and Corritori Consulting will help clients at every step of the development process, from early discovery through commercialization, to prepare for review and approval by the FDA as well as ex-US agencies. The alliance builds on pharmaceutical market integration trends as companies attempt to adapt and scale with seamless internal and external collaborations.

“This alliance amplifies Flagship’s ability to offer regulatory and laboratory biomarker development strategies at all stages of the approval process,” said Meredith James, Flagship’s Chief Operating Officer. “Corritori Consulting’s expertise and deep understanding of regulatory standards and pathways provides concise, stepwise regulatory support in a time and cost-efficient manner. Together, Flagship and Corritori integrate seamlessly with a client’s development team through the entire development process to better ensure FDA and therapeutic success.”

“Our scientific and regulatory leadership and client success track record make Corritori Consulting uniquely suited to support the complex development required by Flagship’s clients,” said Suzana Corritori, President of Corritori Consulting. “We offer complementary services and solid experience to help clients be more efficient. With so many agency guidelines and regulations, there are many potential ways to address a challenge and we’re excited to help Flagship’s clients to find the right approach throughout the development process.”

About Flagship Biosciences

Founded in 2009 and headquartered in Westminster, Colorado, Flagship Biosciences, Inc. is a technology-driven tissue analysis services company delivering the most accurate and informative data available. It is revolutionizing tissue analysis to improve drug development and diagnostics using the power of AI with a consultative approach. Flagship’s services and technology dramatically improve on the data and interpretation from traditional pathology methods, eliminating variability and bringing new insights to tissue analysis results. With expert scientific consultation on every project, Flagship’s team interprets results, contextualizes tissue biology, and identifies the best course for success. flagshipbio.com

About Corritori Consulting Inc.

Corritori Consulting Inc. is an Orange County-based drug development consulting service firm founded in 2008 by Suzana Corritori, MD, Ph.D., MSc., whose career spans over 30 years in biopharmaceutical and medical device product development. Corritori Consulting Inc. provides comprehensive, multidimensional drug development and regulatory expertise in both the domestic and international arenas, integrating medical, clinical, nonclinical, and translational science elements for an effective and targeted regulatory product development.

###

For more information please contact Pamela Curran of Stratos Global Marketing, at pam@stratosglobalmarketing.com or +1 (303) 818 9316.

Share article on social media or email:

1-800-PetMeds® To Partner With Best Friends Animal Society For #GivingTuesdayNow Donation Drive


News Image

We’re grateful to 1-800-PetMeds® for its commitment to help pets in shelters find a permanent home. We know we won’t be able to achieve our mission without critical funds from our corporate partners.

Around 2,200 homeless pets are killed in shelters across the United States each day. 1-800-PetMeds® is supporting Best Friends’ mission to end that by helping to provide veterinary services, community education, and other resources to help more animals find their forever homes.

Best Friends is the only national animal welfare organization dedicated to ending the killing of dogs and cats in America’s shelters. A leader in the no-kill movement, Best Friends runs the nation’s largest no-kill sanctuary for companion animals, adoption centers and spay and neuter facilities in Los Angeles and Salt Lake City as well as lifesaving programs in partnership with more than 1,400 rescue groups and shelters across the country. To learn more, visit Bestfriends.org.

1-800-PetMeds® will host a matching gift campaign on #GivingTuesdayNow to support the life-saving initiatives of Best Friends Animal Society®. 1-800-PetMeds® will match contributors’ donations on #GivingTuesdayNow up to $25,000. #GivingTuesdayNow will take place on Tuesday, May 5th, 2020.

You may find more information about this special event here!

“We’re looking forward to the day when there are no more homeless pets needlessly dying in shelters. With the help of our pet family community, we are proud to host this donation drive to support Best Friends Animal Society. Together, we can support the goal of providing a brighter future to our homeless animals in greatest need.” says Larissa Schenck, Director of Marketing at 1-800-PetMeds®.

“We’re grateful to 1-800-PetMeds® for its commitment to help pets in shelters find a permanent home,” said Eric Rayvid, director of PR, Best friends Animal Society. “We know we won’t be able to achieve our mission without critical funds from our corporate partners.”

About 1-800-PetMeds®

Founded in 1996, Petmeds.com is America’s Most Trusted Pet Pharmacy® providing fast, easy, and helpful service to over ten million customers across the U.S. by delivering prescription and non-prescription medications and pet supplies for less, direct to the consumer through its 1-800-PetMeds® toll-free number, on the Internet through its website Petmeds.com, or with the 1-800-PetMeds® mobile app available for free at Google Play for Android and the App Store for iOS.

About #GivingTuesdayNow

#GivingTuesdayNow is a global day of giving and unity, set to take place on May 5, 2020 as an emergency response to the unprecedented need caused by COVID-19. The day is designed to drive an influx of generosity, citizen engagement, business and philanthropy activation, and support for communities and nonprofits around the world. It’s a day when we can all come together and give back in all ways, no matter who or where we are.

Share article on social media or email:

Improving Peripheral Blood Processing – Introducing a Novel, Automated Alternative to Reagents and Centrifugation, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

This webinar presentation will provide cutting edge researchers who need to process peripheral blood an overview of this new system’s underlying technology, capabilities and performance.

The critical upstream processes of cell sorting and concentration have remained largely unchanged for decades. Researchers have relied on permutations of the 100-year-old centrifuge, 50-year-old density gradient media, or 30-year-old bead approach. While one can manipulate speeds, antibodies and concentrations, the underlying limitations of manual handling, e.g. excessive cell manipulation, labor-intensiveness and performance inconsistency have persisted.

At the same time, as today’s cell and gene-driven research environments are increasingly dependent on downstream highly sophisticated (and high-priced) analytical tools such as mass cytometry and single-cell profiling, upstream sample preparation has taken on critical significance. Sensitivity to red blood cell, platelet and reagent contamination have only increased and reliance on artificial cell populations such as PBMCs, which lack the influential granulocyte component, limit our understanding of in vivo biology.

In mass-cytometry and flow cytometry, significant contaminants can decrease the ability to capture critical target events. Furthermore, scRNA sequencing, a high cost analysis, also benefits from low impurities. The calls for a more stable, time-efficient, reliable, high-yield, automated cell processing solution for sample preparation have only grown louder.

In response to this need, MicroMedicine has developed a novel, microfluidics-based system for cell differentiation, selection and concentration. This innovative approach, called SorterraTM, is a label-free, automated, easy-to-use and train system, which does not involve centrifugation. As a result, Sorterra offers improvements in dedicated labor time, cell yield and purity, consistency, and reliability.

This webinar presentation will provide cutting edge researchers who need to process peripheral blood an overview of this new system’s underlying technology, capabilities and performance.

Join Melanie Scully, PhD, Applications Team Lead, MicroMedicine and Nirav “Rav” Sheth, VP, Commercial Development, MicroMedicine in a live webinar on Friday, May 15, 2020 at 12pm EDT (5pm BST/UK).

For more information or to register for this event, visit Improving Peripheral Blood Processing – Introducing a Novel, Automated Alternative to Reagents and Centrifugation.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

ABOUT MICROMEDICINE

MicroMedicine, Inc., is a life sciences company with an innovative and proven microfluidics platform for high-volume processing of biological fluids for the purposes of research and clinical applications. Founded at Massachusetts General Hospital in 2015, MicroMedicine is committed to transforming research, clinical diagnostics, and cell therapy with novel innovations. The patented microfluidic platform can be utilized for multiple applications, including cell isolation, cell concentration, and fluid exchange. The company resides in the heart of Boston’s life sciences ecosystem in Waltham, Massachusetts, USA. For more information about MicroMedicine, Inc., please call 617-744-1918 or visit micromedicine.com.

To learn more about MicroMedicine visit micromedicine.com

Contact:

Rav Sheth

Email: rav@micromedicine.com

Share article on social media or email:

American College of Lifestyle Medicine Announces Addition of Telehealth Leader Fruit Street Health to its Lifestyle Medicine Corporate Roundtable


News Image

“Fruit Street programs can reverse the progression of disease, reduce personal health care costs and reduce the risk for heart disease and other chronic conditions.”

The American College of Lifestyle Medicine (ACLM) has announced the addition of telehealth leader Fruit Street Health (Fruit Street) to its Lifestyle Medicine Corporate Roundtable, a group of individuals and organizations whose collective vision is sustainable human health, a sustainable health care system and a sustainable world.

Fruit Street is a physician-funded diabetes prevention and weight loss program delivered via telehealth company based in New York City. Fruit Street currently offers the only CDC-recognized online diabetes prevention program (DPP) delivered through live video chat with Registered Dietitians. Founded in 2014 as a public benefit corporation, Fruit Street has raised capital from more than 300+ physicians who are dedicated to making a lasting social impact in health care.

Fruit Street is proven to help people lose five to seven percent of their body weight, which not only improves their overall health, it can reverse the progression of disease, reduce personal health care costs and reduce the risk for heart disease and other chronic conditions. As the only fully recognized diabetes prevention program that is delivered by live group video, Fruit Street offers a more effective program, based on the proven impact of social support which increases engagement and results in a higher rate of goal attainment.

This April, Fruit Street launched CovidMD™, a new risk assessment, triage and telemedicine platform created to help the health care system respond to the COVID-19 pandemic. On CovidMD, the public is given trusted information about their exposure and health risk for developing serious illness from COVID-19 based on CDC guidelines, personalized details on available healthcare resources, and the opportunity to connect with a doctor via live video chat for a telemedicine appointment. Learn more about CovidMD at https://covidmd.com.

Ken Germano, PhD, DrPH, MPH, Executive Vice President of Physician Engagement and Network Development for Fruit Street, said as a public benefit corporation, the company seeks to work and collaborate with organizations and associations who share a common mission in creating social impact.

“Based on the common threads of science and evidence-based health services, continuing education, valid programming and broad reaching professional forums, together, ACLM and Fruit Street/CovidMD may leverage a collective asset regarding our joint commitment to promoting healthy lifestyle choices through our platforms and professional populations,” said Germano.

“Fruit Street offers telemedicine products that are unique to the market,” said ACLM President Dexter Shurney, MD, MBA, MPH, FACLM, DipABLM. “CovidMD is just one example of their agility to bring necessary software forward to provide practical solutions. ACLM welcomes Fruit Street to the Lifestyle Medicine Corporate Roundtable.”

The Corporate Roundtable of the American College of Lifestyle Medicine convenes health care and lifestyle thought leaders, with a keen focus on the power of Lifestyle Medicine to transform health and health care. Roundtable members explore effective Lifestyle Medicine clinical applications, strategies for accelerating reimbursement, and adoption and analysis of potential business-related opportunities. The Roundtable launched in 2015 and has grown to include more than 30 active member organizations.

ABOUT THE AMERICAN COLLEGE OF LIFESTYLE MEDICINE:

ACLM is the medical professional society for those dedicated to the advancement and clinical practice of Lifestyle Medicine as the foundation of a transformed and sustainable health care system. Lifestyle Medicine is the use of a whole food, plant-predominant dietary lifestyle, regular physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connection as a primary therapeutic modality for treatment and reversal of chronic disease.

More than a professional association, ACLM is a galvanized force for change. ACLM addresses the need for quality education and certification, supporting its members in their individual practices and in their collective mission to domestically and globally promote Lifestyle Medicine as the first treatment option, as opposed to a first option of treating symptoms and consequences with expensive, ever increasing quantities of pills and procedures. ACLM members are united in their desire to identify and eradicate the root cause of disease. Learn more at http://www.LifestyleMedicine.org.

ABOUT FRUIT STREET:

Fruit Street Health is a physician-funded telehealth company that offers a comprehensive telemedicine software platform for healthcare providers. Fruit Street currently offers the only CDC-recognized online diabetes prevention program (DPP) delivered through live video chat with Registered Dietitians. Founded in 2014 as a public benefit corporation, Fruit Street has raised more than $20 million in capital from over 300+ physicians who are dedicated to making a lasting social impact in healthcare. Visit https://www.fruitstreet.com/.

Share article on social media or email:

A Primer, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

Advanced techniques have recently been developed to account for complex challenges such as interval censoring, cured patients and treatment crossover.

Economic evaluations for health technology assessments (HTAs) often rely on estimates of “time-to-event” for patient outcomes, such as time to disease progression, time to first stroke, or time to death to assess the costs and benefits of a treatment or intervention.

Analysis of time-to-event data – also known as survival analysis – can provide estimates of survivor functions and event rates that inform these economic analyses. As well as characterising event rates over an observed period of time, such as the duration of a clinical trial, survival analysis techniques are used to extrapolate the results over a lifetime to generate estimates of mean survival benefit.

Estimates of an intervention’s cost-effectiveness can be sensitive to the methods applied in modelling and extrapolating survival data. Typically, these projections are performed using various parametric models, with each model making different assumptions about the underlying hazard function. Advanced techniques have recently been developed to account for complex challenges such as interval censoring, cured patients and treatment crossover.

Join Victoria Paly, MHS, Principal, Global Health Economics, ICON and Dhvani Shah, MS, Principal, Global Health Economics, ICON in a live webinar on Friday, May 15, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Survival Analysis in HTA Submissions: A Primer.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Kevin Kearns & Ireland’s 13-Year-Old Brandon Foster Teach Patience, Commitment Immunity Protection On Sharon Kleyne VoiceAmerica


Air Date: 27 April 2020

Guests: Kevin Kearns, Boston, Massachusetts, founder/CEO of Burn with Kearns and Beach Bod Transformation; All-star Conference Presenter for IDEA, the world’s largest association for fitness and wellness professional http://www.burnwithkearns.com & his student, 13-year-old Brandon Foster from Ireland.

https://www.voiceamerica.com/episode/123221/stay-fit-and-strong-to-fight-the-coronarirus

https://video.search.yahoo.com/search/video?fr=aaplw&p=kevin+kearns+youtube#id=3&vid=612a3f507d447ec4a93bfa8dd81f7a52&action=click

*

During the virus pandemic, Bio Logic Aqua® Research Water Life Science® will be providing regular updates at http://www.sharonkleynehour.com/Coronavirus.php 

International fitness instructor Kevin Kearns of Boston, Massachusetts and his student, 13-year-old Brandon Foster in Ireland talk with VoiceAmerica radio host Sharon Kleyne about immunity protection, new hygiene practices during the COVID-19 pandemic and after, and the physical and mental training that drives exercise and the martial arts.

“Only water made time into eternity,” says Bio Logic Aqua® Research Water Life Science® founder Sharon Kleyne. “We must drink a lot of clean water so that the body flushes out harmful toxins. Each of our organs has a percentage of water. The surface of the eye is 99 percent water. We are all learning immunity protection,” Kleyne continues. “pH balance means acid mantel protection in the body. Drink a lot of water,” Kleyne encourages. “Breathe in, breathe out and get those toxins out of there! Then follow up with a healthy diet that’s right for you. Diet is the next medicine.”

Kearns in Boston says that during the COVID-19 pandemic he has been concerned about five things.

  • 1. Obesity
  • 2. Lack of movement
  • 3. Depression
  • 4. Potential suicide
  • 5. Alcohol & drug abuse

Kearns, whose system is designed to “make people feel good about exercise,” describes how he was a weak, bullied kid who discovered his purpose and self-confidence in the martial arts. Kearns believes that his young student, Foster, is a good role model for young people everywhere.

Foster brings passion and optimism to his daily life and learning. “Every single day there is always something new to do and learn.” Growing up, Foster describes how “he was taught to eat well and stay away from unhealthy foods. “My father taught me how to breathe properly,” he shares. “Yoga is a great help.”

Kleyne asks Foster what advice he might give to kids his age. “Exercise,” says Foster without hesitation. “Find something to do that makes you happy,” he adds, “and have fun when exercising with the physical and mental training.” Foster, who shares that at the age of four he wanted to be a superhero, then a scientist, studies algorithm and artificial intelligence and is never bored. Now he loves writing, telling stories and wants to be a fulltime writer.

Kleyne, Kearns and Foster all say that we need patience and passion to learn all we need to learn about immunity protection and the importance of water to new hygiene practices.

If you would like to listen to the internationally syndicated The Power of Water® & Your Health sponsored by Nature’s Tears® EyeMist®, naturally pH balanced water technology for acid mantel protection, on VoiceAmerica featuring international fitness trainer and coach Kevin Kearns, his student 13-year-old Brandon Foster in Ireland and Global Health Olympics™ founder and Water Life Science® educator and evaporative dry eye researcher Sharon Kleyne as they discuss fitness, training, breathing, martial arts, viruses, infectious disease, education, water and evaporation, follow this link: https://www.voiceamerica.com/episode/122821/how-to-keep-kids-strong-and-healthy-to-fight-coronavirus

Tune in to recent talk radio shows with Sharon Kleyne featuring Dr. Gerald Pollack, Ph.D. (https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water), Pam Bonney (https://www.voiceamerica.com/episode/122945/how-to-protect-our-frontline-healthcare-professionals), Kevin Kearns (https://www.voiceamerica.com/episode/122821/how-to-keep-kids-strong-and-healthy-to-fight-coronavirus), and Rodrigo L. Romulo, M.D. (https://www.voiceamerica.com/episode/122421/encore-infectious-disease-101-the-fundamentals-of-controlling-and-fighting-infectious-disease).

If you would like to watch a brief, entertaining educational film that demonstrates the application of the new Dry Eye Solution® technology Nature’s Tears® EyeMist®, sponsor of Sharon Kleyne’s talk radio program, go here: https://www.youtube.com/watch?v=l0gOr8TB45U

Share article on social media or email: